mudpie

Company profile · 3 min read

Adialante is building a mobile MRI service for clinics

Adialante proposes a compact mobile MRI delivered to clinics for a flat per-scan fee, starting with prostate imaging before biopsy.

Published · Updated

Adialante is building a mobile MRI service for clinics that want diagnostic imaging without buying a scanner, building a shielded room or installing a full imaging department.

What it does

The company describes a compact, mobile, diagnostic-grade MRI delivered to a clinic for a flat per-scan fee. It is starting with prostate imaging before biopsy and says the mobile unit can arrive at the practice, with the clinic paying for completed scans rather than buying the hardware. Adialante homepage YC profile

The current website says the company has 11 clinics that reserved a slot and $19.75M in signed LOIs. Those are company-reported commercial signals, not evidence that the system is cleared, broadly available or clinically equivalent to every MRI workflow.

The careers page shows the stage more clearly than the headline. Adialante is hiring MRI technologists for a live prostate-MRI pilot on a conventional 1.5T system, alongside quality and regulatory roles tied to a 510(k) submission for its next-generation platform. Adialante careers

Why I’d look closer

The business model is the interesting part. A clinic can consider adding imaging capacity without owning the full machine, facility and technical team. For urology practices and other sites with enough patient volume, a mobile unit could make the question operational rather than capital-intensive.

The founders’ backgrounds are relevant. The YC profile describes Parker Jenkins and Efrain Torres as biomedical engineers building a new MRI approach; the company says the team has developed new hardware, physics and algorithms.

What could make it the wrong choice

This is medical infrastructure. The buyer needs to ask about regulatory status, clinical validation, radiologist coverage, patient scheduling, reimbursement, service continuity, image quality, installation and the exact meaning of “diagnostic-grade.”

The public pages describe signed commitments and a pilot, but they do not establish that the next-generation scanner is cleared for every proposed use. A clinic should not treat a public LOI or a company claim as a substitute for its own clinical, legal and procurement review.

My editorial take

I would shortlist Adialante for a urology or specialty clinic that has the patient volume and operational need to evaluate mobile MRI seriously. I would not treat it as a buy-now medical device from the homepage. The fit is a service-and-regulatory partnership decision first, and a hardware purchase decision never.

Quick facts

Field Sourced detail
Product Mobile diagnostic-grade MRI service
Starting use case Prostate imaging before biopsy
Commercial model Flat per-scan fee; no equipment purchase stated
Current stage Pilot, signed clinic commitments and regulatory work described publicly
Main fit question Can the clinic support the clinical, regulatory and scheduling workflow?

Sources checked

Adialante homepage, YC profile, launch material and careers page were checked on 2026-09-19.

Cohort context

Adialante is listed in Spring 2026. In our 2026-09-18 directory snapshot, 17 of 193 listed companies in that cohort have YC’s primary industry label Healthcare (8.8%). This is a current-directory comparison, not an original intake count or a performance ranking. Nine-cohort dataset.

Public website snapshot

Observed 2026-09-19T16:16:02.669Z in raw homepage HTML. This records visible metadata and advertised links, not agent execution or product quality.

Signal Homepage observation
Product description metadata Observed
Canonical link Observed
H1 or H2 heading Observed
Typed structured data Observed
Docs/developer link Not observed in this response
Pricing link Not observed in this response
llms.txt link Not observed in this response
Markdown alternate Not observed in this response

Public observations · Collection method. Missing links here do not establish that a capability or file is absent elsewhere.

About the author

I cofound Lazyweb and publish Mudpie. This is an owner-written publication, not an independent testing organization. Research notes distinguish observations, sourced reporting and editorial judgment.

First1000 ↗ · X ↗